Armolipid Plus supplement

Armolipid Plus is a popular dietary supplement formulated to support cardiovascular health and manage cholesterol levels. It was originally developed in Italy by Rottapharm|Madaus, a company renowned for its pharmaceutical research. The product is primarily manufactured in Italy, adhering to high European quality standards for health supplements.

Over the years, the ownership of the brand has transitioned through major corporate acquisitions. In 2014, the Swedish pharmaceutical company Meda AB acquired Rottapharm. Subsequently, in 2016, Meda was acquired by Mylan, a global pharmaceutical giant based in the United States. Following the merger of Mylan with Pfizer's Upjohn division in 2020, the brand now falls under the umbrella of Viatris Inc., a leading global healthcare company headquartered in Pennsylvania, USA. In Italy, the brand is managed through the local entity Viatris Italia.